SARS-CoV-2 - Prazosine - Therapeutic Candidates

SARS-CoV-2 - Prazosine - Therapeutic Candidates


Prazosin is an antihypertensive derived from quinazoline which belongs to the class of alpha-blockers. Prazosin is used to lower blood pressure by relaxing blood vessels. This action is due to the fact that prazosin is selective for alpha1 receptors on vascular smooth muscle. These receptors are responsible for the vasoconstrictive action of norepinephrine, which is responsible for raising blood pressure. Because of these effects, prazosin is indicated in the treatment of high blood pressure, anxiety and post-traumatic stress disorder and panic disorder.
A clinical study has begun to determine the potential of prazosin to slow and possibly prevent one of the worst effects of Covid-19, cytokine storm. This study was based on research in mice that showed that prazosin could prevent this cytokine storm phenomenon, as well as a study of a cohort of patients suffering from acute respiratory distress from a variety of causes.

Search result : 106 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 23
  • [3H] 2
  • Biochemicals 77
  • Inhibitor/Antagonist/Agonist 26
  • Radiochemicals 2
  • Buffers and reagents 1
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
NB-48-0767-100MG
 100mg 
A11914-100
 100mg 
orb1218546-5mg
 5mg 
orb1305946-25mg
 25mg 
orb1218546-25mg
 25mg 
orb1305946-5mg
 5mg 
orb1305946-10mg
 10mg 
orb1305946-50mg
 50mg 
orb1900213-1000mg
 1000mg 
orb1900212-250mg
 250mg 
orb1900214-100mg
 100mg 
orb134408-100mg
 100mg 
orb545829-250mg
 250mg 
orb545829-50mg
 50mg 
orb1900211-500mg
 500mg 
orb134408-250mg
 250mg 
orb134408-1g
 1g 
orb1686060-5mg
 5mg 
orb1686060-100mg
 100mg 
orb1686060-50mg
 50mg